Publications by authors named "Omer Anis"

Introduction: The workload for benign prostatic hyperplasia (BPH) surgery is expected to rise with an increase in life expectancy and a growing population. Surgical modalities for BPH have evolved, shifting toward minimally invasive transurethral procedures. This study aimed to investigate the trends in BPH surgical procedures across medical centers in Israel.

View Article and Find Full Text PDF

Objectives: To assess the association between overactive bladder syndrome (OAB) and the metabolic syndrome (MetS).

Patients And Methods: A population-based study was conducted to compare OAB patients with age-, sex- and ethnicity-matched control subjects regarding the prevalence of the parameters of the MetS, with respect to obesity, hyperlipidemia, hypertension and diabetes mellitus. The characteristics of the OAB population were assessed.

View Article and Find Full Text PDF

Background: While cannabis-based medicine is being commonly used in patients with movement disorders, there is a scarcity of publications regarding the effect of cannabis on dystonia. We aimed to describe medical cannabis use in patients with dystonia and related pain.

Methods: We employed a structured interview to obtain data on the cannabis treatment regimen, perception of effectiveness and side effect profile.

View Article and Find Full Text PDF

Intravesical bacillus Calmette-Guérin (BCG) is a common and highly effective treatment for non-muscle invasive urothelial carcinoma of the urinary bladder. BCG may cause an autoimmune reaction in some patients. One hundred and fifty-eight papers were analyzed, for a total of hundred and thirty patients with reactive arthritis, sixty patients with ocular manifestations and eighteen patients with other rheumatologic diseases.

View Article and Find Full Text PDF
Article Synopsis
  • * It included 681 patients with IC/BPS and 3,376 matched controls, revealing a higher prevalence of CSU in the IC/BPS group (20% vs. 13.7%).
  • * The research concluded that there is a significant association between IC/BPS and CSU, suggesting potential allergic or immune factors involved in IC/BPS development.*
View Article and Find Full Text PDF
Article Synopsis
  • Botulinum toxin is a recognized treatment for various urologic conditions affecting the lower urinary tract.
  • Intravesical injection of the toxin has become a supported method for treating patients with overactive bladder that doesn't respond to medication.
  • More research is needed to evaluate the effectiveness of botulinum toxin for other urologic issues like benign prostate enlargement and premature ejaculation.
View Article and Find Full Text PDF

Botulinum toxin has been at the center of attention in the last decades as a treatment option in several urologic diseases related to lower urinary tract function. Intravesical injection of the toxin is recommended for two main indications: neurogenic detrusor over-activity and idiopathic detrusor over-activity, resistant to oral therapy. In certain cases, clinical response to treatment is less than ideal, despite previous response.

View Article and Find Full Text PDF

contains more than 500 constituents, yet the anticancer properties of the vast majority of cannabis compounds remains unknown. We aimed to identify cannabis compounds and their combinations presenting cytotoxicity against bladder urothelial carcinoma (UC), the most common urinary system cancer. An XTT assay was used to determine cytotoxic activity of extracts on T24 and HBT-9 cell lines.

View Article and Find Full Text PDF

Despite the surge in cannabis chemistry research and its biological and medical activity, only a few cannabis-based pharmaceutical-grade drugs have been developed and marketed to date. Not many of these drugs are Food and Drug Administration (FDA)-approved, and some are still going through regulation processes. Active compounds including cannabinergic compounds (i.

View Article and Find Full Text PDF

Objective: To assess long-term outcome after selective arterial embolization (SAE) as first-line treatment for large or symptomatic AML.

Design, Setting, And Participants: Data from a prospectively maintained database on 71 patients who underwent SAE for large or symptomatic AML were reviewed. Patients with sporadic and tuberous-sclerosis-complex (TSC) were included.

View Article and Find Full Text PDF

We have previously reported that the topical application of erythropoietin (EPO) to cutaneous wounds in rats and mice with experimentally induced diabetes accelerates their healing by stimulating angiogenesis, reepithelialization, and collagen deposition, and by suppressing the inflammatory response and apoptosis. Aquaporins (AQPs) are integral membrane proteins whose function is to regulate intracellular fluid hemostasis by enabling the transport of water and glycerol. AQP3 is the AQP that is expressed in the skin where it facilitates cell migration and proliferation and re-epithelialization during wound healing.

View Article and Find Full Text PDF